Deoxypodophyllotoxin Induces a Th1 Response and Enhances the Antitumor Efficacy of a Dendritic Cell-based Vaccine
Authors:
Open Access
- 1 January 2011
- journal article
- Published by XMLink in Immune Network
- Vol. 11 (1) , 79-94
Abstract
Lee JS, et al. Immune Netw. 2011 Feb;11(1):79-94. https://doi.org/10.4110/in.2011.11.1.79Keywords
This publication has 51 references indexed in Scilit:
- Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectinJournal of Clinical Investigation, 2008
- Immunomodulation by herpesvirus U51A chemokine receptorviaCCL5 and FOG‐2 down‐regulation plus XCR1 and CCR7 mimicry in human leukocytesEuropean Journal of Immunology, 2008
- PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activationJournal of Experimental Medicine, 2008
- YopJ targets TRAF proteins to inhibit TLR-mediated NF-?B, MAPK and IRF3 signal transductionCellular Microbiology, 2007
- TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1‐type responseEuropean Journal of Immunology, 2007
- RIP2 mediates LPS‐induced p38 and IκBα signaling including IL‐12 p40 expression in human monocyte‐derived dendritic cellsEuropean Journal of Immunology, 2007
- Tumor-Infiltrating Dendritic Cell Subsets of Progressive or Regressive Tumors Induce Suppressive or Protective Immune ResponsesCancer Research, 2005
- Dendritic cell immunotherapy with poly(d,l‐2,4‐diaminobutyric acid)‐mediated intratumoral delivery of the interleukin‐12 gene suppresses tumor growth significantlyCancer Science, 2005
- MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsCancer Gene Therapy, 2002
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991